EDGAR Filing Documents for 0001564590-20-056952

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001564590-20-056952

Filing Date

2020-12-14

Accepted

2020-12-14 08:56:35

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	apvo-s3.htm	S-3	742523
2	EX-1.2	apvo-ex12_180.htm	EX-1.2	324238
3	EX-4.9	apvo-ex49_11.htm	EX-4.9	453448
4	EX-4.12	apvo-ex412_7.htm	EX-4.12	165216
5	EX-4.13	apvo-ex413_8.htm	EX-4.13	160806
6	EX-4.14	apvo-ex414_9.htm	EX-4.14	173647
7	EX-5.1	apvo-ex51_10.htm	EX-5.1	34857
8	EX-23.1	apvo-ex231_6.htm	EX-23.1	2787
9	GRAPHIC	guuynp5bbdjv000003.jpg	GRAPHIC	4203
10	GRAPHIC	guuynp5bbdjv000001.jpg	GRAPHIC	4203
11	GRAPHIC	guuynp5bbdjv000002.jpg	GRAPHIC	4203
12	GRAPHIC	g5eb5ivcdsbt000001.jpg	GRAPHIC	8123
	Complete submission text file	0001564590-20-056952.txt		2087675

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121

Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500

Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)